





![]()






Mary Bird Perkins has been a leader in the fight against cancer for over 50 years. Endowed gifts provide long-term sustainability needed to advance cancer care and provide vital resources across the continuum of care. We are committed to offering world-class oncology services, provided by a team of experts who are 100% focused on cancer. Together we triumph!

When we launched the Legacy Challenge just a few short years ago, we did so with a bold and ambitious vision: to grow the Mary Bird Perkins Cancer Foundation endowment to $50 million by 2025. This goal was rooted in our unwavering belief that the future of cancer care should be just as strong, compassionate, and innovative as the care we provide today.
Thanks to your generosity, we’ve not only reached that goal—we’ve done so ahead of schedule.
But this milestone represents far more than a number. For me, it’s deeply personal.
I’ve had the unique opportunity to experience Mary Bird Perkins from two perspectives: first, as a grateful patient, and later, as a member of the Foundation Board. I know firsthand the impact your support makes— because I’ve lived it.
Ten years ago, I was diagnosed with prostate cancer. What began with surgery evolved into a longer journey that led me to Mary Bird Perkins for radiation therapy. I’ll never forget the compassion of my oncologist, the expertise of the technicians, and the kindness of the entire care team. They didn’t just treat my cancer—they treated me like family.
My care team had a profound impact on my life, but it was the 42 days I spent in the Radiation Oncology waiting room that truly transformed me. During that time, I connected with fellow patients and their families, listened to their stories, and shared in their fears, hopes, and dreams. What started as a daily obligation quickly became something I looked forward to—an opportunity to be part of a community bound by resilience and compassion.
After completing my treatment, I felt compelled to give back. I picked up the phone and asked how I could help advance the mission. That call led me to the Foundation Board, where I’ve had the honor of working alongside passionate leaders committed to the same cause that changed my life.
Already, these funds are expanding access to screenings and prevention, driving innovation like Adaptive Radiation Therapy, and helping us attract and retain the region’s most talented specialists.
My wife, Cary, and I are profoundly grateful to witness this world-class care—and equally grateful to each of you for making it possible. This progress doesn’t happen by chance. It happens because people like you believe in a future where everyone has access to the best possible cancer care. You understand that investing in cancer care is investing in the health and strength of our communities—across every family, every neighborhood, every parish, and every generation.
On behalf of the entire Board of Directors, thank you. Your support plays an essential role in redefining what’s possible for cancer care in the Gulf region.
The Legacy Challenge is proof that when we come together with vision and compassion, we can secure tomorrow’s cancer care—today.

With deep gratitude,

Rolfe
Miller, Chair
Mary Bird Perkins Cancer Foundation Board of Directors
Throughout the past fiscal year, donor support has been the power behind the transformational endowment growth, coupled with favorable market returns and strong portfolio performance. Granting to Mary Bird Perkins Cancer Center is only made possible by steadfast donor commitment to the mission and an unwavering vision to secure the future of cancer care for the health of Louisiana and the Gulf South.
Market Value and Activity (July 1, 2024 – June 30, 2025)
BEGINNING ENDOWMENT FUND BALANCE
The market value of Endowment Investments and Receivables as of July 1, 2024.
INCOME OR CONTRIBUTIONS AND INVESTMENT GAINS/LOSSES
GRANT TO MARY BIRD PERKINS CANCER CENTER
Supporting prevention, research, innovation, education, patient care, patient support and survivorship programs, and Cancer Services.
EXPENDITURES
ENDING ENDOWMENT FUND BALANCE
The market value of the Endowed Investments and Receivables as of June 30, 2025.
OVERALL INVESTMENT PERFORMANCE OF 13.4% (NET OF INVESTMENT FEES) $33,488,277 $3,414,053 ($1,035,632) ($270,726) $35,595,972
$35.5 MILLION ENDOWMENT DOLLARS UNDER INVESTMENT
ENDOWMENT VALUE IN ASSETS AND PLANNED GIFTS 4 NEW ENDOWMENT FUNDS 62 ENDOWMENT FUNDS
*Grants from Mary Bird Perkins Cancer Foundation began in 2012. $6 MILLION TOTAL GRANTED TO MARY BIRD PERKINS CANCER CENTER* $52.9 MILLION
As of June 30, 2025, our total endowment value is $35,595,972 with a return of 13.4% over the prior year. Over the past fiscal year, market returns have rebounded, and we continue to outperform our benchmark index for the year. Due to generous donor support and fiscally responsible leadership, the endowment continues to grow.
In May 2023, the Foundation engaged Brown Advisory, an independent investment management and strategic advisory firm committed to delivering a combination of first class performance, strategic advice and the highest level of client service, to assist with the endowment and investment portfolio. We look forward to continued success with this relationship in the upcoming years.
The endowment allocation – the percent exposure to each asset class is shown as of June 30, 2025. Endowment investing policies are designed to maximize long-term results at an acceptable level of investment risk. Endowed gifts are invested in Mary Bird Perkins Cancer Foundation’s pooled endowment, a globally diversified portfolio of assets including publicly traded stocks, bonds and alternative investments.
Total Endowment Value

Allocation (June 2025)
Hedge
For Dr. Constance Blunt, the fight against cancer starts long before a diagnosis. As an oncologist at Mary Bird Perkins Cancer Center and the Medical Director for its Prevention on the Go (POGO) program, she is equally at home in an exam room, accompanying the mobile team in the heart of a rural Louisiana town or providing an educational presentation to community members.
Her path to prevention work was shaped both by her medical training in underserved areas and by personal experiences. She remembers a close family friend—a young, hardworking mother—whose ovarian cancer was discovered too late. “I’ve seen how life can get in the way of care,” Dr. Blunt says. “Work, kids, transportation—it all adds up. And those delays can change everything.”

That understanding drives her commitment to POGO’s expansion into Central and North Louisiana. In many of these communities, specialty care is hours away, and primary care is scarce.
POGO meets people where they are, offering free cancer screenings, along with navigation services to connect patients to follow-up care quickly, if needed. One case stands out in Dr. Blunt’s mind: a woman in her 30s who felt a lump in her breast but was told it would be weeks before she could see a doctor. “She called POGO and had a mammogram the next day,” Dr. Blunt recalls. “Within two weeks, she was meeting with a physician to start treatment. That speed made a real difference for her.”
For Dr. Blunt, these are more than medical wins—they’re moments that ripple through communities. “When someone gets screened and understands why it matters, they share that with family and friends. That’s how awareness spreads,” she says.
This work also feeds her own sense of purpose. “Oncology can be heavy work,” she admits. “But going into a community, talking with people, helping them prevent cancer—it’s incredibly rewarding. It’s one of the parts of my job that brings joy and balance.”
She credits donors with making this reach possible. “Our healthcare system alone can’t close every gap,” Dr. Blunt says. “Donor support is what allows us to expand, to hire more staff, to add new services. Every person we screen is here because someone cared enough to give.”
“Some of my patients travel two, even two-and-a-half hours to see a doctor,” she explains. “For someone who’s sick, that’s not just inconvenient—it can be impossible.”
With every mobile unit deployed and every community served, POGO brings Mary Bird Perkins’ mission closer to home—proving that early detection and prevention can happen anywhere.
The first time Krystal Kirby, PhD, learned about the Elekta Unity system, she knew it would change everything.
A physicist with a passion for imaging, Dr. Kirby graduated from Mary Bird Perkins and LSU’s Dr. Charles M. Smith Medical Physics Program before completing her residency elsewhere. So when the chance came to return to Mary Bird Perkins as a diagnostic physicist, she embraced it— joining the launch of one of the most innovative radiation programs in the country. “When I came on board, my role as a diagnostic physicist was a bit of an unknown,” says Dr. Kirby. “But there was a sense that we were on the cusp of something transformative.”
That transformation came to life with the launch of Adaptive Radiation Therapy—a groundbreaking approach to cancer care made possible by the generosity of Mary Bird Perkins donors. At its core, adaptive therapy allows clinicians to see a patient’s anatomy in real time and change the treatment plan while the patient is on the table. Instead of relying on scans taken weeks before, treatment adapts in the moment— offering unmatched precision, especially for cancers that move with the body, like those in the lungs or abdomen.
“Cancer doesn’t stand still,” Kirby explains. “Now, our treatment doesn’t have to either.” Generous donor support helped Mary Bird Perkins acquire the Elekta Unity—one of only a few dozen in the entire country, and the only one in Louisiana. This technology fuses highresolution MRI with radiation therapy, allowing for unprecedented accuracy. It also reduces the number of treatments dramatically. Instead of needing dozens of sessions, some patients now complete therapy in just three to five visits.
That’s life-changing for patients who must travel long distances or navigate barriers to care. “We see patients every day who would’ve struggled to make it through traditional treatment plans,” Dr. Kirby says. “This technology removes those barriers.”
Beyond the clinical benefits, the emotional impact is profound. “When patients realize they can get through this in a matter of days, not weeks, it transforms how they feel about their diagnosis. It brings hope,” she says.

Today, Dr. Kirby continues to push the boundaries of what’s possible—mentoring students, leading safety efforts, and conducting research into the future of image-guided therapy. But she’s quick to credit the source of progress.
“This doesn’t happen without donors,” she says. “Their investment brought this program to life. And every patient who walks through our doors benefits because of their investment in the future of cancer care.”
For Rebecca and Dyke Nelson, supporting Mary Bird Perkins has always been more than a financial contribution—it’s a family commitment.
Their journey with the Cancer Center began more than 20 years ago, when a friend invited Rebecca to help plan a fundraising event. “At the time, it was their only fundraiser,” she recalls. “But once we understood the impact Mary Bird Perkins was making—not just the quality of care, but the reach into underserved communities—we knew this was something we wanted to be part of long-term.”
Over the decades, the couple’s involvement deepened. Rebecca joined the Foundation’s board of directors in 2017, eventually serving as Director Emeritus and joining the Cancer Center board in 2023. Together, she and Dyke established a named endowed fund—an enduring expression of their belief in the mission, and a commitment to ensuring its future.
But this isn’t just their legacy. It’s a family one.
With three children entering adulthood, the couple has made it a priority to model what community stewardship looks like. “We’ve always told our kids, this is our family’s investment— not just ours,” Dyke says. “We want them to understand that giving is about responsibility, not just resources.”
From helping with fundraising events to contributing in their own ways, the next generation is learning what it means to support a cause that matters. And by involving them in the decision to create an endowed fund, Rebecca and Dyke are laying the groundwork for a lasting, generational impact.

They also want others to know that building a legacy is more accessible than it may seem.
“This was a stretch gift for us,” Rebecca shares. “But the Foundation made it easy and approachable. And thanks to matching opportunities, we were able to make a more significant impact than we ever thought possible.”
Their hope is clear: that their fund will help expand access to care for patients who might otherwise fall through the cracks—those without insurance, without transportation, or without the means to navigate a complex healthcare system on their own. “This is about more than just our family,” Dyke says. “It’s about our community and our responsibility to one another.”
Together, the legacy they’re building is not just about giving back. It’s about building forward for future prevention, treatment and support service transformations.
Courtney Nuckolls had just turned 40 when she found a lump.
She wasn’t scheduled for a mammogram until later that summer—but something in her gut told her not to wait. “Absolutely not,” she said. “I called Mary Bird Perkins.”
What happened next is a story of care, speed, and compassion. “I knew from when I worked on the Cancer Center’s philanthropy team how committed they are to the community. But when I became the patient, it all became very real.”
Within days of reaching out, Courtney was connected to the Cancer Center’s renowned Prevention on the Go screening program. “I had a Saturday screening, watched my son graduate on Monday, and by Tuesday morning, I was at Woman’s Hospital,” she says. That level of rapid response—and the seamless collaboration between providers—set the tone for the care that followed.

The diagnosis: six cancerous masses in both breasts. Two different types of cancer. One of the tumors Courtney had detected turned out to be the least of her doctors’ concerns. Some of the others were the size of a grain of sugar—tiny, but aggressive. And yet, thanks to early screening and fast follow-up care, she caught it in time.
That access mattered. Courtney had recently left her job and was navigating a high-deductible insurance plan. “I had just stepped away from work and didn’t know what was coming next,” she says. “Looking back, it was a blessing. Six weeks later, I was facing a cancer diagnosis. When I turned to Mary Bird Perkins, they said, ‘This is what we do. We’ve got you.’ And they did—every step of the way.”

Donor-supported programs helped Courtney receive timely screening, navigation, and aggressive treatment—right when she needed it most. Now in remission, she’s a caregiver for her mother, a youth mentor at her church, and a proud mom to Ethan, who was by her side for every single appointment.
“Everyone’s story is different,” she says. “But I know mine could have gone another way if Mary Bird Perkins hadn’t been there. Donors make that possible—for me and for so many others. They make sure you’re not facing a cancer diagnosis alone.”
Our community has come together over generations to create a meaningful legacy that will secure the future of cancer care and help us triumph over cancer. It is because of YOU that we are building a powerful endowment that will leave a lasting legacy for everyone to receive world-class cancer care, right here at home. We’re excited to announce we’ve reached our goal of $50 million in assets and planned gifts. Thanks to the dedication and generous support of our Lipsey Legacy Society members, our endowment is providing hope and driving new ideas and discoveries that will improve cancer care for generations.


The Lipsey Legacy Society, named in honor of Anna B. Lipsey, a founding board member, honors those who have made a lasting legacy to Mary Bird Perkins Cancer Foundation through a planned gift or a named endowed fund. Every Society member is making a difference today and tomorrow, strengthening our position as the leading cancer care organization in Louisiana and across the region.
2024 - 2025
• Jason Brady
• Lee Michael Berg Family
• Mary Olive Pierson*
• Chuck Schwing*
The Lipsey Legacy Society honors those individuals who have made a contribution to Mary Bird Perkins Cancer Foundation through a planned gift or a named endowed fund.
• Robelynn H. Abadie
• Lisa and Tom Adamek & Family Fund
Lisa and Tom Adamek
• Mr. and Mrs. John W. Barton, Jr.
• Sybil A. Bateman*
• Lee Michael Berg Family Fund
• Mr. and Mrs. James M. Bernhard, Jr.
• Dr. and Mrs. Frederic Billings III Fund
Susan and Frederic Billings
• The Ben Blanchard Memorial Endowment Fund*
Susan, Mark and Chris Blanchard
• Kim A. Boudreaux
• Mrs. Jane Thibaut Boyce*
• Mr. and Mrs. John C. Boyce Family Fund
Melanie and John Boyce
• The Brady Family Endowment Fund
Jason Brady
• Kate and Tee Brown
• Renee Hebert Bryant Memorial Fund*
• Joan* and Herbert H. Butt
• Mr. and Mrs. J. H. Campbell, Jr.
• Shirley A. Carey*
• Robert R. Casey*
• The Ella Chance Family
• Pat Cheramie*
• The Coates Family Fund
Beverly and Dudley* Coates
• Jess Willard Cockerham*
• The Colley Family Endowment Fund
Mr. and Mrs. Allan B. Colley
• Charles Newsam Conner*
• Theresa Frey Cooper*
• Violet T. Crum*
• Jean H. and Louis D. Curet Family Fund*
Jean H. and Louis D. Curet*
• Mr. D. Cecil Delaune*
• Ms. Elaine T. Delaune*
• Leonard Boyd Delaune*
• Wilbon “W. T.” Doughty*
• The Gina and Rex Ellison Endowment Fund
Gina and Rex Ellison
• Hazel Ewing*
• Isiah J. Ewing*
• The Favre Family Fund for Innovation
Art E. Favre
• William A. Ferguson*
• Dr. Robert Fields Patient Care Fund
• The Raymond and Mary Gettier Fund*
• Charlie V. Giambelluca*
• Devera and Jerry Goss Family Fund
• Devera and Jerry Goss Research Fund
Devera and Jerry Goss
• Isaac and Florence Gregorie*
• The Barrie and G. Lee Griffin Endowment Fund
Mr. and Mrs. G. Lee Griffin*
• Davis A. Gueymard*
• David S. Hanson, MD and Jolene K. Johnson, MD
• Mrs. Cecile B. Harrell*
• Ava and Cordell Haymon Fund Ava and Cordell Haymon

• Heart of a Hero Fund
• Dat C. Hoang in honor of Lai Cao & Thinh Hoang*
• The D. Jensen Holliday Family Fund
Estelle and Jensen* Holliday
• Holly Hollis Stars Endowment Fund*
• Jerry Dale O’Donovan Hornsby* in loving memory of Frank Gore
• Jeanne C. and David M. James
• Dr. Sheldon A. Johnson
• Donna and J. Gerard Jolly
• Mr. and Mrs. Robert H. Jones
• Karnival Krewe de Louisiane Endowment Fund
• Esther Kent*
• The Shirley C. and J. Barker Killgore Research Fund*
• Wojciech Antoni Krotoski*
• Mr. and Mrs. Anthony S. Kurlas Family Fund
Ginger and Tony Kurlas
• L. Perrie Lambert Memorial Fund*
• Hillary Lanaux Endowment Fund*
Mr. Hilaire Dubertrand* and Mrs. Ethel Langenstein Lanaux
• Mary Alicia and Bettye Lauret*
• Marianne and R. Upton Lea, Jr. Memorial Fund*
• Clifton J. LeBlanc*
• Richard A. Lipsey and Susan Haspel Lipsey Family Fund in memory of Anna B. Lipsey
Susan and Richard Lipsey
Laurie Lipsey
Wendy Lipsey
• Wilbur Marvin Endowment Fund* in honor of Donna M. Saurage
• Mauti Cancer Fund
• Kathy and Frank McArthur Endowed Fund
Kathy* and Frank McArthur
• Lady Katharine McLaurin*
• Tracey and Ty McMains
• The McMains Family Foundation Endowed Fund
The McMains Family
• Anne and Tom Meek Endowed Fund
Anne and Tom Meek
• The Miller Family Fund
Cary and Rolfe Miller
• Marguerite H. Mills*
• T.J. Moran Fund
Mr. Thomas J. Moran*
• Suzanne Motion*
• Rosalie Moyse*
• Stephen R. Musso*
• Rebecca and Dyke Nelson & Family Fund
Rebecca and Dyke Nelson
• Ron* and Corinne Helm Ness
• Mrs. Eleanor P. Newman*
• Virginia B. and John Noland
• Evelyn and Paul Nowacki
• Cindy and Craig Nuckolls
• The Lauren Savoy Olinde Endowment Fund*
• Robins-O’Quin Endowed Family Fund
Gail and Bill O’Quin
• The Phillips Family Fund
Claudia and Gary Phillips
• Mary Olive Pierson*
• The David C. and Jeannie Price Fund*
• President’s Endowment Fund in honor of Todd Stevens
• Barbara Virginia Rathbone
• The Rathbone Family Fund
Barbara Rathbone
Randee and Jack Rathbone IV
Michele and Richard* Rathbone
Shawnee and Steve McCord
• Dr. and Mrs. M. J. Rathbone, Jr.*
• Michele and Richard* Rathbone
• The Dee Dee and Kevin P. Reilly, Sr. Endowment Fund*
• The Sarah Madison Romero Endowment Fund*
• Jan and Sanford Roy Family Endowed Fund
Jan and Sanford* Roy
• Allison and Blanchard Sanchez
• Marjorie H. Sanders*
• H. N. Saurage IV Family Fund
Laurie and Hank Saurage
• The Saurage Family Fund
Donna M. Saurage
• The Melissa Margaret Mary Savoie Endowment Fund*
• Ellen Chadwick Sessions Endowed Fund
Ellen C. Sessions
• Ms. Ruth C. Sessions*
• The Simmons Family Fund
Betty Jean Simmons*
• Beverly Carson Smiley
• Dr. Charles M. Smith Medical Physics Fund
Dr. Charles M. Smith*
• Smith-Gwatney Endowed Fund in honor of Scotty Gwatney
Jon S. Gwatney
• Bernice and Edward Spiess*
• Kelli and Todd Stevens
• Emily C. Stich
• The Tillman Stogner Endowment Fund
Tillman Stogner
• Mr. Robert M. Stuart, Sr.
• Corry and Nathaniel Tannehill
• Dr. and Mrs.* O. M. Thompson, Jr.
• Pam and Mike Wall
• The Jean and Will Wilcox Fund
Jean and Will Wilcox
• Ann Wilkinson
• Drs. Charles and Brooke Wood and Family Fund
Drs. Charles and Brooke Wood
• Anonymous (7)
* Fondly Remembered
Through strategic investments in mobile prevention clinics and new Southshore facilities, we’ve eliminated geographic barriers to care—providing comprehensive patient support services and transportation assistance through over 100 trips to ensure no one faces cancer alone due to financial constraints.
Your support provided educational funding for nine future physicists in the Dr. Charles M. Smith Medical Physics Program. These emerging leaders will advance cancer care in Louisiana for years to come, driving both groundbreaking research and life-saving clinical innovations.
Your generosity enabled six infusion nursing professionals to attend the premier Oncology Nursing Society conference, bringing leading-edge treatment knowledge directly to patient bedsides and ensuring our community receives the most current, evidence-based cancer care.
By funding the expansion of the Cancer Center’s Supportive and Palliative Care Program and specialized navigation services, we’ve made it possible for patients to receive holistic support that addresses not just their medical needs, but their emotional, social, and spiritual well-being throughout their entire cancer journey.
By investing in dedicated clinical research staff and specialized equipment across the Northshore and Southshore, we’ve brought breakthrough clinical trials directly to patients in even more communities —establishing comprehensive research capabilities that ensure no one misses access to innovative therapies due to geographic limitations.
2024-2025
Mary Bird Perkins Cancer Foundation
ROLFE MILLER Chair
DAVID PERRY Vice Chair
SHELIA STERLING Secretary/Treasurer
NATHANIEL TANNEHILL Immediate Past Chair
JONAS FONTENOT, PhD, MBA President and CEO
SUSAN BLANCHARD
JONATHAN BRUSER
ART FAVRE
BRETT FURR
KIMBERLY GINN
KATIE GRAVES
ROSE HUDSON
ANDI KIRKPATRICK
BEAU OLINDE
CRAIG STEVENS
EMERITUS BOARD OF DIRECTORS
JOHN BARTON, JR.
AZA BOWLIN
TEE BROWN
JAY CAMPBELL
LOUIS CURET*
JERRY GOSS
G. LEE GRIFFIN*
JEANNE JAMES
JERRY JOLLY
RICHARD LIPSEY
MICK MAULDIN
JIM MCILWAIN
STEVEN MOORE
REBECCA NELSON
GAIL O’QUIN
BILL PETERS
BLANCHARD SANCHEZ
DONNA SAURAGE
TODD STEVENS
PAUL THOMPSON

TRIUMPHING OVER CANCER, TOGETHER

Thank you for being a member of the Mary Bird Perkins Cancer Foundation community and for your support and visionary investment in the health of Louisiana and the Gulf South.
We are grateful for your generosity.
Reaching our $50 million campaign goal is more than a milestone - it’s a testament to the unwavering commitment of an entire community. This achievement belongs to our generous donors, dedicated physicians and team members, visionary Board and Foundation leaders, and our partners across the region who stood with us every step of the way. Your belief in our mission has fueled advancements in technology, research, and patient care that will impact lives for years to come.
I am deeply grateful for every gift, every act of advocacy, and every expression of trust in Mary Bird Perkins Cancer Foundation. Together, we have built a stronger future—one that will continue to support innovation, expand access, and deliver the highest quality cancer care close to home.
As we celebrate this remarkable accomplishment, we also begin a new chapter for our Foundation. The focus ahead is on sustaining and growing the programs this campaign has made possible, ensuring that our patients benefit from the very best care, today and for generations to come.

With heartfelt gratitude,

Jonas Fontenot, PhD, MBA Chief Executive Officer Mary Bird Perkins Cancer Center



